Your search for bevacizumab returned 12 results

Researchers investigated the association between nonalcoholic fatty liver disease and early-onset colorectal cancer according to anatomical site.

Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.

Increased recurrence-free survival seen for patients with high-risk HCC following resection or ablation.

The IMbrave050 study included 662 patients with HCC at high risk for recurrence after surgical resection or ablation with curative intent.

At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab

Outcomes at 2 years comparable among patients with diabetic macular edema receiving aflibercept monotherapy, bevacizumab first

Substantial improvement observed through month 12, which persisted through month 60, but lessened with fewer treatments

The approval was based on data from the phase 3 KEYNOTE-826 trial.

Pembrolizumab plus chemotherapy with or without bevacizumab could be a new standard of care for first-line therapy in metastatic cervical cancer.

The checkpoint inhibitor cemiplimab improved survival in patients with recurrent/metastatic cervical carcinoma compared with single-agent chemotherapy.